SUVmax sheds light on prognosis for patients with NSCLC

02/9/2013 | AuntMinnie.com (free registration)

Maximum standardized uptake value as measured by PET/CT may help improve prediction of progression-free survival in patients with early-stage non-small cell lung cancer undergoing stereotactic body radiation therapy, according to findings presented at an imaging and radiation therapy conference. The study involved patients who had PET/CT imaging with SUVmax assessment before undergoing treatment. SUVmax assessment may allow for more tailored treatment strategies and ultimately better outcomes, a researcher said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA